Differential Diagnosis of Livedo

Introduction

Livedo refers to a distinctive mottled, reticulate (net-like), reddish-blue or violaceous discoloration of the skin. The pattern results from slow or obstructed blood flow through the cutaneous vasculature, with relative hypoxia in the central zones of vascular territories (at the watershed areas between arterioles) causing the darker central color, while the periphery of each network remains perfused and appears as pale or erythematous rings.

The critical clinical distinction is between Livedo Reticularis (physiologic or benign, reversible) and Livedo Racemosa (pathologic, associated with significant underlying disease). This differentiation has profound implications for workup and prognosis.

---

21.1 Anatomy and Pathophysiology

Understanding the basis of livedo requires knowledge of cutaneous vascular anatomy.

21.1.1 Cutaneous Vascular Unit

• Cutaneous arterioles ascend vertically from the deep dermis/subcutis through the dermis.
• Each arteriole supplies a cone-shaped territory of skin.
• The central zone of this cone is the tip of the arterial territory—furthest from the ascending arteriole.
• The peripheral zone is near the arteriole itself.
• At the boundaries between adjacent cones, there are watershed areas with comparatively lower blood flow.

21.1.2 Mechanism of Livedo Pattern

• When blood flow slows or oxygen extraction increases:
  • The central (watershed) zones become relatively hypoxic → appear blue/violaceous (deoxygenated hemoglobin).
  • The peripheral zones (near arterioles) remain pink/red.
  • This creates a reticulated (net-like) pattern of blue surrounded by pink.

21.1.3 Causes of Slow Blood Flow

1. Physiologic vasospasm (cold exposure).
2. Increased blood viscosity (cryoglobulins, polycythemia).
3. Vascular obstruction (thrombi, emboli, vasculitis).
4. Inflammation of vessel walls (vasculitis → narrowed lumen).

---

21.2 Livedo Reticularis vs. Livedo Racemosa

This distinction is fundamental.

[!IMPORTANT] Clinical Test: Warm the affected limb for 15-20 minutes.

• If the pattern disappears completely → Livedo Reticularis (benign).
• If the pattern persists → Livedo Racemosa → INVESTIGATE.

---

21.3 Causes of Livedo Reticularis (Physiologic/Benign)

21.3.1 Primary (Idiopathic) Livedo Reticularis

• Common in young women.
• Precipitated by cold exposure, emotional stress.
• Completely reversible with warming.
• No associated systemic disease.
• Also called "cutis marmorata" when seen in neonates and infants (physiologically normal due to immature vasomotor control).

21.3.2 Secondary Causes (Still Reversible but May Have Triggers)

• Severe cold exposure
• Fever/dehydration (increased viscosity)
• Medications causing vasospasm

---

21.4 Causes of Livedo Racemosa (Pathologic)

Livedo racemosa indicates significant underlying disease and requires thorough investigation.

21.4.1 Thromboembolic Causes

Antiphospholipid Syndrome (APS)

• Definition: Autoimmune disorder characterized by recurrent arterial and/or venous thrombosis and pregnancy morbidity in the presence of antiphospholipid antibodies.
• Antibodies: Lupus anticoagulant, Anti-cardiolipin antibodies, Anti-β2-glycoprotein I.
• Cutaneous Manifestations:
  • Livedo Racemosa (most common skin finding, 25-50% of patients).
  • Skin ulcers, digital gangrene.
  • Superficial thrombophlebitis.
• Association: Primary APS or Secondary (associated with SLE).
• Catastrophic APS (CAPS): Multi-organ thrombosis with high mortality.

Sneddon Syndrome

• Definition: Livedo racemosa + cerebrovascular disease (ischemic strokes or TIAs), often at young age.
• Demographics: Predominantly young to middle-aged women.
• Pathology: Non-inflammatory thrombotic vasculopathy of medium-sized arteries—"endarteritis obliterans."
• Association: Up to 40% have antiphospholipid antibodies (overlap with APS).
• Prognosis: Progressive. Risk of recurrent strokes, cognitive decline.

Cholesterol Emboli Syndrome (Atheroembolism)

• Setting: Elderly patients with atherosclerotic disease. Often precipitated by vascular procedures (angiography, aortic surgery) or anticoagulation.
• Mechanism: Cholesterol crystals from atheromatous plaques embolize to small vessels.
• Clinical Features:
  • Livedo racemosa (legs, feet, abdomen).
  • "Blue toe syndrome": Ischemic discoloration of toes with palpable pedal pulses.
  • Renal failure (worsening after catheterization).
  • Eosinophilia (transient).
  • Multi-organ involvement (GI, CNS).
• Histopathology: Cholesterol clefts (needle-shaped birefringent spaces) within vessels.

Cryoglobulinemia

• Definition: Circulating immunoglobulins that precipitate at cold temperatures.
• Types:
  • Type I: Monoclonal (myeloma, Waldenström).
  • Type II/III: Mixed (associated with Hepatitis C).
• Clinical Features:
  • Livedo.
  • Palpable purpura.
  • Peripheral neuropathy.
  • Renal involvement (membranoproliferative GN).
  • Raynaud's phenomenon.
• Diagnosis: Check cryoglobulins (sample must be kept at 37°C during collection).

21.4.2 Vasculitic Causes

Polyarteritis Nodosa (PAN)

• Definition: Necrotizing vasculitis of medium-sized arteries.
• Cutaneous Features:
  • Livedo racemosa (most common skin finding).
  • Subcutaneous nodules along arteries (tender).
  • Skin ulcers (punched-out, around ankles/lower legs).
  • Digital gangrene (rare).
• Systemic Features: Peripheral neuropathy (mononeuritis multiplex), renal involvement (hypertension, infarcts), abdominal pain (mesenteric ischemia), myalgia, arthralgia.
• Association: Hepatitis B (classic), Hepatitis C.
• Exclusive Cutaneous PAN: Skin-limited variant. No systemic involvement. Better prognosis.

21.4.3 Microvascular Occlusion

Livedoid Vasculopathy (Atrophie Blanche)

• Definition: Non-inflammatory, thrombotic disorder of dermal vessels. NOT a true vasculitis.
• Clinical Features:
  • Painful, recurrent purpuric papules and ulcers on lower legs/ankles.
  • Heal to form "Atrophie blanche": Ivory-white, stellate, atrophic scars with peripheral telangiectasia.
  • Livedo pattern often accompanies.
• Association: Hypercoagulable states, Antiphospholipid syndrome.
• Histology: Fibrin thrombi in small dermal vessels. Minimal inflammation.
• Treatment: Anticoagulation, not immunosuppression (since not inflammatory).

Calciphylaxis (Calcific Uremic Arteriolopathy)

• Setting: End-stage renal disease (ESRD), dialysis patients. Also in non-uremic (obesity, warfarin, hyperparathyroidism).
• Pathogenesis: Calcium deposition in media of small arteries → thrombosis → necrosis.
• Clinical Features:
  • Livedo racemosa on trunk, thighs, buttocks.
  • Painful, necrotic ulcers with eschar formation.
  • Subcutaneous nodules (indurated, tender).
• Prognosis: Very poor (1-year mortality up to 50-80%).
• Diagnosis: Biopsy (calcification of vessels), but biopsy may trigger ulceration.

---

21.5 Clinical Approach

21.5.1 History

• Cold sensitivity: Exacerbates physiologic livedo.
• Thrombotic history: DVT, PE, stroke, miscarriages → APS.
• Recent vascular procedures: Cholesterol emboli.
• Hepatitis risk factors: PAN, Cryoglobulinemia.
• Dialysis/ESRD: Calciphylaxis.
• Medications: Warfarin (non-uremic calciphylaxis).

21.5.2 Examination

• Pattern analysis: Regular vs. broken/irregular.
• Response to warming: Persistent = Racemosa.
• Associated findings:
  • Subcutaneous nodules → PAN.
  • Atrophie blanche scars → Livedoid vasculopathy.
  • Blue toes with palpable pulses → Cholesterol emboli.
  • Skin necrosis → Calciphylaxis, APS.
  • Purpura → Cryoglobulinemia, vasculitis.

21.5.3 Investigations

---

21.6 Diagnostic Algorithm

Loading diagram...

---

21.7 Summary Comparison Table

---

21.8 Clinical Pearls

1. Warming test is crucial: If livedo disappears completely with warming, it is benign livedo reticularis. No further workup needed.
2. Livedo racemosa = Investigate: Persistent, broken pattern always warrants workup for underlying thrombotic or vasculitic disease.
3. APS triad: Livedo + Thrombosis + Pregnancy loss → Check antiphospholipid antibodies.
4. Post-catheterization livedo + blue toes + eosinophilia → Cholesterol emboli syndrome.
5. Subcutaneous nodules along arteries + livedo → Polyarteritis nodosa. Check Hep B.
6. Painful ulcers healing to white scars → Livedoid vasculopathy. NOT true vasculitis → treat with anticoagulation.
7. ESRD + livedo + necrotic ulcers → Calciphylaxis. High mortality. Wound care, sodium thiosulfate.